Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients

Standard

Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients. / Rogasch, Julian M M; Steffen, Ingo G; Riedel, Sandra; Apostolova, Ivayla; Wertzel, Heinz; Achenbach, H Jost; Steinkrüger, Ferdinand L G A; Kalinski, Thomas; Schultz, Meinald; Schreiber, Jens; Amthauer, Holger; Furth, Christian.

in: EUR RADIOL, Jahrgang 26, Nr. 8, 08.2016, S. 2808-18.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Rogasch, JMM, Steffen, IG, Riedel, S, Apostolova, I, Wertzel, H, Achenbach, HJ, Steinkrüger, FLGA, Kalinski, T, Schultz, M, Schreiber, J, Amthauer, H & Furth, C 2016, 'Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients', EUR RADIOL, Jg. 26, Nr. 8, S. 2808-18. https://doi.org/10.1007/s00330-015-4093-5

APA

Rogasch, J. M. M., Steffen, I. G., Riedel, S., Apostolova, I., Wertzel, H., Achenbach, H. J., Steinkrüger, F. L. G. A., Kalinski, T., Schultz, M., Schreiber, J., Amthauer, H., & Furth, C. (2016). Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients. EUR RADIOL, 26(8), 2808-18. https://doi.org/10.1007/s00330-015-4093-5

Vancouver

Bibtex

@article{e8dd08edd9384dbdb3b027b00735af97,
title = "Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients",
abstract = "OBJECTIVES: To analyze the diagnostic performance of dual time point imaging (DTPI) for pre-therapeutic lymph node (LN) staging in non-small cell lung cancer (NSCLC).METHODS: This was a retrospective analysis of 47 patients with NSCLC who had undergone DTPI by PET (early + delayed) using F18-fluorodeoxyglucose (FDG). PET raw data were reconstructed iteratively (point spread function + time-of-flight). LN uptake in PET was assessed visually (four-step score) and semi-quantitatively (SUVmax, SUVmean, ratios LN/primary, LN/liver, and LN/mediastinal blood pool). DTPI analyses included retention indices (RIs), Δ-ratios and changes in visual score. Histology or cytology served as standards of reference. Accuracy was determined based on ROC analyses.RESULTS: Thirty-six of 155 LNs were malignant. DTPI accuracy was low for all measures (visual assessment, 24.5%; RI SUVmax, 68.4%; RI SUVmean, 65.8%; Δ-ratios, 63.9-76.1%) and significantly inferior to early PET. Accuracies of early (range, 86.5-92.9%) and delayed PET (range, 85.2-92.9%) were comparable. At early PET, accuracy of the visual score (92.9%) was similar or superior to semi-quantitative analyses (range, 86.5-92.3%).CONCLUSIONS: Using a modern PET/CT device and novel image reconstruction, neither additional delayed PET nor DTPI analyses improved the accuracy of PET-based LN staging. Dedicated visual assessment criteria performed very well.KEY POINTS: • DTPI did not improve accuracy of PET-based LN staging in NSCLC. • Analyzed SUV ratios were not superior to LN SUVmax or SUVmean. • A four-step visual score may allow highly accurate, standardized LN assessment.",
keywords = "Adult, Aged, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung, Female, Fluorodeoxyglucose F18, Humans, Image Processing, Computer-Assisted, Lung Neoplasms, Male, Middle Aged, Neoplasm Staging, Positron Emission Tomography Computed Tomography, ROC Curve, Radiopharmaceuticals, Reproducibility of Results, Retrospective Studies, Journal Article",
author = "Rogasch, {Julian M M} and Steffen, {Ingo G} and Sandra Riedel and Ivayla Apostolova and Heinz Wertzel and Achenbach, {H Jost} and Steinkr{\"u}ger, {Ferdinand L G A} and Thomas Kalinski and Meinald Schultz and Jens Schreiber and Holger Amthauer and Christian Furth",
year = "2016",
month = aug,
doi = "10.1007/s00330-015-4093-5",
language = "English",
volume = "26",
pages = "2808--18",
journal = "EUR RADIOL",
issn = "0938-7994",
publisher = "Springer",
number = "8",

}

RIS

TY - JOUR

T1 - Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients

AU - Rogasch, Julian M M

AU - Steffen, Ingo G

AU - Riedel, Sandra

AU - Apostolova, Ivayla

AU - Wertzel, Heinz

AU - Achenbach, H Jost

AU - Steinkrüger, Ferdinand L G A

AU - Kalinski, Thomas

AU - Schultz, Meinald

AU - Schreiber, Jens

AU - Amthauer, Holger

AU - Furth, Christian

PY - 2016/8

Y1 - 2016/8

N2 - OBJECTIVES: To analyze the diagnostic performance of dual time point imaging (DTPI) for pre-therapeutic lymph node (LN) staging in non-small cell lung cancer (NSCLC).METHODS: This was a retrospective analysis of 47 patients with NSCLC who had undergone DTPI by PET (early + delayed) using F18-fluorodeoxyglucose (FDG). PET raw data were reconstructed iteratively (point spread function + time-of-flight). LN uptake in PET was assessed visually (four-step score) and semi-quantitatively (SUVmax, SUVmean, ratios LN/primary, LN/liver, and LN/mediastinal blood pool). DTPI analyses included retention indices (RIs), Δ-ratios and changes in visual score. Histology or cytology served as standards of reference. Accuracy was determined based on ROC analyses.RESULTS: Thirty-six of 155 LNs were malignant. DTPI accuracy was low for all measures (visual assessment, 24.5%; RI SUVmax, 68.4%; RI SUVmean, 65.8%; Δ-ratios, 63.9-76.1%) and significantly inferior to early PET. Accuracies of early (range, 86.5-92.9%) and delayed PET (range, 85.2-92.9%) were comparable. At early PET, accuracy of the visual score (92.9%) was similar or superior to semi-quantitative analyses (range, 86.5-92.3%).CONCLUSIONS: Using a modern PET/CT device and novel image reconstruction, neither additional delayed PET nor DTPI analyses improved the accuracy of PET-based LN staging. Dedicated visual assessment criteria performed very well.KEY POINTS: • DTPI did not improve accuracy of PET-based LN staging in NSCLC. • Analyzed SUV ratios were not superior to LN SUVmax or SUVmean. • A four-step visual score may allow highly accurate, standardized LN assessment.

AB - OBJECTIVES: To analyze the diagnostic performance of dual time point imaging (DTPI) for pre-therapeutic lymph node (LN) staging in non-small cell lung cancer (NSCLC).METHODS: This was a retrospective analysis of 47 patients with NSCLC who had undergone DTPI by PET (early + delayed) using F18-fluorodeoxyglucose (FDG). PET raw data were reconstructed iteratively (point spread function + time-of-flight). LN uptake in PET was assessed visually (four-step score) and semi-quantitatively (SUVmax, SUVmean, ratios LN/primary, LN/liver, and LN/mediastinal blood pool). DTPI analyses included retention indices (RIs), Δ-ratios and changes in visual score. Histology or cytology served as standards of reference. Accuracy was determined based on ROC analyses.RESULTS: Thirty-six of 155 LNs were malignant. DTPI accuracy was low for all measures (visual assessment, 24.5%; RI SUVmax, 68.4%; RI SUVmean, 65.8%; Δ-ratios, 63.9-76.1%) and significantly inferior to early PET. Accuracies of early (range, 86.5-92.9%) and delayed PET (range, 85.2-92.9%) were comparable. At early PET, accuracy of the visual score (92.9%) was similar or superior to semi-quantitative analyses (range, 86.5-92.3%).CONCLUSIONS: Using a modern PET/CT device and novel image reconstruction, neither additional delayed PET nor DTPI analyses improved the accuracy of PET-based LN staging. Dedicated visual assessment criteria performed very well.KEY POINTS: • DTPI did not improve accuracy of PET-based LN staging in NSCLC. • Analyzed SUV ratios were not superior to LN SUVmax or SUVmean. • A four-step visual score may allow highly accurate, standardized LN assessment.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Carcinoma, Non-Small-Cell Lung

KW - Female

KW - Fluorodeoxyglucose F18

KW - Humans

KW - Image Processing, Computer-Assisted

KW - Lung Neoplasms

KW - Male

KW - Middle Aged

KW - Neoplasm Staging

KW - Positron Emission Tomography Computed Tomography

KW - ROC Curve

KW - Radiopharmaceuticals

KW - Reproducibility of Results

KW - Retrospective Studies

KW - Journal Article

U2 - 10.1007/s00330-015-4093-5

DO - 10.1007/s00330-015-4093-5

M3 - SCORING: Journal article

C2 - 26560731

VL - 26

SP - 2808

EP - 2818

JO - EUR RADIOL

JF - EUR RADIOL

SN - 0938-7994

IS - 8

ER -